In a paper published in the May 5 online issue
of The Oncologist, researchers at the University
of California, San Diego School
of Medicine and Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013 using a molecular tumor board — a
new type
of advisory group comprised
of multidisciplinary experts, including those in the
fields of tumor genetics, basic science and
bioinformatics.